OUP Management Co., LLC
- SEC CIK
- 0001880124
- Latest filing
- Nov 9, 2023
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 1, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 15
- 0 vs. Q2 2022
- Portfolio value
- $64.2M
- −$8.44M (−11.6%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 2,937,615 | $11.8M | 18.4% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 989,232 | $11.8M | 18.3% | 00.0% | Unchanged | History |
| DICEDICE Therapeutics, Inc. | COM | 536,693 | $10.9M | 16.9% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM | 603,762 | $10.0M | 15.6% | 00.0% | Unchanged | History |
| IONQIonQ, Inc. | COM | 1,177,597 | $5.97M | 9.3% | −200,000−14.5% | Reduced | History |
| CYTCyteir Therapeutics, Inc. | COM | 2,469,572 | $4.74M | 7.4% | −5,000−0.2% | Reduced | History |
| VORVor Biopharma Inc. | COM | 374,714 | $1.49M | 2.3% | 00.0% | Unchanged | History |
| DTILPrecision Biosciences Inc | COM | 1,123,913 | $1.46M | 2.3% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 862,543 | $1.42M | 2.2% | 00.0% | Unchanged | History |
| EVLVEvolv Technologies Holdings, Inc. | COM CL A | 652,475 | $1.38M | 2.2% | −930,246−58.8% | Reduced | History |
| LENZLENZ Therapeutics, Inc. | COM | 406,308 | $1.29M | 2.0% | 00.0% | Unchanged | History |
| LABPLandos Biopharma, Inc. | COM | 1,237,667 | $804.0K | 1.3% | −375,097−23.3% | Reduced | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 1,025,697 | $587.0K | 0.9% | 00.0% | Unchanged | History |
| SPROSpero Therapeutics, Inc. | COM | 249,070 | $498.0K | 0.8% | 00.0% | Unchanged | History |
| QTTBQ32 Bio Inc. | COM | 64,000 | $103.0K | 0.2% | 00.0% | Unchanged | History |